Blocking of Human Immunodeficiency Virus Type-1 Virion Autolysis by Autologous p2gag Peptide

Journal of Biochemistry

Volumn 135, Issue 3, 2004, Pages 447-453

  Misumi, Shogo ^a   Morikawa, Yukimi ^a   Tomonaga, Mitsunori ^a   Ohkuma, Kouichi ^a   Takamune, Nobutoki ^a   Shoji, Shozo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

HIV 1; HIV 1 protease; p2gag peptide; Processing; Suicidal inhibition

Indexed keywords

ALANINE; ALANYLGLUTAMYLALANYLMETHIONYLSERYLGLUTAMINYLVALYLTHREONYLASPARAGINE; ALANYLGLUTAMYLALANYLMETHIONYLSERYLGLUTAMINYLVALYLTHREONYLASPARAGINYLTHREONY LALANYLTHREONYLISOLEUCYLMETHIONINE; AMINO ACID; ASPARAGINE; METHIONINE; MONOCLONAL ANTIBODY; PEPTIDE; STRUCTURAL PROTEIN; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; AUTOLYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; SUBSTITUTION REACTION; SUPERNATANT; T LYMPHOCYTE; VIRION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODY SPECIFICITY; AUTOLYSIS; CELL LINE; FEMALE; GENE PRODUCTS, GAG; GENE PRODUCTS, TAT; HIV CORE PROTEIN P24; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MICE; MUTATION; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1942455749     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/jb/mvh052     Document Type: Article

References (29)

1. Kohl, N.E., Emini, E.A., Schleif, W.A., Davis, L.J., Heimbach, J.C., Dixon, R.A., Scolnick, E.M., and Sigal, I.S. (1988) Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl Acad. Sci. USA 85, 4686-4690
2. Vaishnav, Y.N. and Wong-Staal, F. (1991) The biochemistry of AIDS. Annu. Rev. Biochem. 60, 577-630
3. gag was found to be a suicide inhibitor of HIV-1 protease. Biochem. Biophys. Res. Commun. 241, 275-280
4. Konvalinka, J., Litterst, M.A., Welker, R., Kottler, H., Rippmann, F., Heuser, A.M., and Kräusslich, H.G. (1995) An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J. Virol. 69, 7180-7186
5. Layne, S.P., Merges, M.J., Dembo, M., Spouge, J.L., Conley, S.R., Moore, J.P., Raina, J.L., Renz, H., Gelderblom, H.R., and Nara, P.L. (1992) Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189, 695-714
6. Pettit, S.C., Moody, M.D., Webbie, R.S., Kaplan, A.H., Nantermet, P.V., Klein, C.A., and Swanstrom, R. (1994) The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68, 8017-8027
7. Shehu-Xhilaga, M., Crowe, S.M., and Mak, J. (2001) Maintenance of the Gag/Gag-Pol Ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J. Virol. 75, 1834-1841
8. Misumi, S., Takamune, N., Ido, Y., Hayashi, S., Endo, M., Mukai, R., Tachibana, K., Umeda, M., and Shoji, S. (2001) Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4. Biochem. Biophys. Res. Commun. 285, 1309-1316
9. 2-terminal myristoyl-Gly-Ser-Ser-Lys src-peptide. Biochem. Biophys. Res. Commun. 170, 657-664
10. v-src, the transforming protein of Rous sarcoma virus. Mol. Cell. Probes 3, 213-224
11. Jacks, T., Power, M.D., Masiarz, F.R., Luciw, P.A., Barr, P.J., and Varmus, H.E. (1988) Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 331, 280-283
12. Wiegers, K., Rutter, G., Kottler, H., Tessmer, U., Hohenberg, H., and Krausslich, H.G. (1998) Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72, 2846-2854
13. Louis, J.M., Clore, G.M., and Gronenborn, A.M. (1999) Auto-processing of HIV-1 protease is tightly coupled to protein folding. Nat. Struct. Biol. 6, 868-875
14. Paulus, C., Hellebrand, S., Tessmer, U., Wolf, H., Kräusslich, H.G., and Wagner, R. (1999) Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein. J. Biol. Chem. 274, 21539-21543
15. Lindhofer, H., von der Helm, K., and Nitschko, H. (1995) In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes. Virology 214, 624-627
16. Pettit, S.C., Sheng, N., Tritch, R., Erickson-Viitanen, S., and Swanstrom, R. (1998) The regulation of sequential processing of HIV-1 Gag by the viral protease. Adv. Exp. Med. Biol. 436, 15-25
17. Shehu-Xhilaga, M., Kraeusslich, H.G., Pettit, S., Swanstrom, R., Lee, J.Y., Marshall, J.A., Crowe, S.M., and Mak, J. (2001) Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation. J. Virol. 75, 9156-9164
18. Derossi, D., Joliot, A.H., Chassaing, G., and Prochiantz, A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-10450
19. Derossi, D., Chassaing, G., and Prochiantz, A. (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8, 84-87
20. Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., and Prochiantz, A. (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271, 18188-18193
21. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L.L., Pepinsky, B., and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl Acad. Sci. USA 91, 664-668
22. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., and Sugiura, Y. (2001) Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840
23. Lin, Y.Z., Yao, S., Veach, R.A., Torgerson, T.R. and Hawiger, J. (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 14255-14258
24. Nagahara, H., Vocero-Akbani, A.M., Snyder, E.L., Ho, A., Latham, D.G., Lissy, N.A., Becker-Hapak, M., Ezhevsky, S.A., and Dowdy, S.F. (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4, 1449-1452
25. Rojas, M., Donahue, J.P., Tan, Z., and Lin, Y.Z. (1998) Genetic engineering of proteins with cell membrane permeability. Nat. Biotechnol. 16, 370-375
26. Rojas, M., Yao, S., and Lin, Y.Z. (1996) Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J. Biol. Chem. 271, 27456-27461
27. Schwarze, S.R., Ho, A., Vocero-Akbani, A., and Dowdy, S.F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572
28. chwarze, S.R. and Dowdy, S.F. (2000) In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21, 45-48
29. Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017